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Abstract
Studies have shown that the quantitative flow ratio (QFR), recently introduced to assess lesion severity from coronary angi-
ography, provides useful prognostic information; however the additive value of this technique over intravascular imaging in 
detecting lesions that are likely to cause events is yet unclear. We analysed data acquired in the PROSPECT and IBIS-4 stud-
ies, in particular the baseline virtual histology-intravascular ultrasound (VH-IVUS) and angiographic data from 17 non-culprit 
lesions with a presumable vulnerable phenotype (i.e., thin or thick cap fibroatheroma) that caused major adverse cardiac 
events or required revascularization (MACE) at 5-year follow-up and from a group of 78 vulnerable plaques that remained 
quiescent. The segments studied by VH-IVUS were identified in coronary angiography and the QFR was estimated. The 
additive value of 3-dimensional quantitative coronary angiography (3D-QCA) and of the QFR in predicting MACE at 5 year 
follow-up beyond plaque characteristics was examined. It was found that MACE lesions had a greater plaque burden (PB) 
and smaller minimum lumen area (MLA) on VH-IVUS, a longer length and a smaller minimum lumen diameter (MLD) on 
3D-QCA and a lower QFR compared with lesions that remained quiescent. By univariate analysis MLA, PB, MLD, lesion 
length on 3D-QCA and QFR were predictors of MACE. In multivariate analysis a low but normal QFR (> 0.80 to < 0.97) 
was the only independent prediction of MACE (HR 3.53, 95% CI 1.16–10.75; P = 0.027). In non-flow limiting lesions with 
a vulnerable phenotype, QFR may provide additional prognostic information beyond plaque morphology for predicting 
MACE throughout 5 years.
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Introduction
Fractional flow reserve (FFR) is the gold standard for 
assessing the physiologic significance of a coronary artery 
lesion and planning treatment. This modality, which also 
appears able to provide useful prognostic information 
even in non-flow limiting lesions [1], involves advance-
ment of a pressure wire across the lesion and adenosine 
administration to achieve hyperaemia and thus it comes 
with additional procedure-related risks of adverse events, 
extended procedure time and increased cost [2]. Quantita-
tive flow ratio (QFR), a wire-free, hyperaemia-free method 
has been recently introduced to overcome these limitations 
and derive FFR from models reconstructed from 3-dimen-
sional quantitative coronary angiography (3D-QCA) [3]. 
Recent clinical studies have supported the potential clini-
cal value of QFR showing that it enables not only accurate 
detection of flow limiting lesions but also identification of 
patients at risk from cardiovascular events [4–7].
Cumulative data has shown that imaging-derived vari-
ables combined with computationally-derived physiologi-
cal indices enables more accurate detection of lesions that 
are likely to progress and cause events. In the EMERLAD 
study, plaque characteristics and the FFR estimated by com-
puted tomography allowed detection of lesions that caused 
myocardial infarction with a higher accuracy than plaque 
morphology (c-index: 0.789 vs. 0.747; P = 0.014) [8]. How-
ever, no study today has assessed whether computationally-
derived FFR—using the QFR software—has additive pre-
dictive value compared with intravascular imaging alone.
Methods
Study design
The present study is a post hoc analysis of data obtained 
from the Intergraded Biomarkers Imaging Study 4 (IBIS-4) 
and the Providing Regional Observations to Study Predic-
tors of Events in the Coronary Tree (PROSPECT) clinical 
studies. The study design of these trials, the definitions and 
endpoints as well as the inclusion and exclusion criteria 
have been described in detail elsewhere [9, 10]. In sum-
mary, the IBIS-4 trial was a prospective multi-modality 
multicenter study which aimed to investigate the effect of 
aggressive statin therapy on plaque composition and burden 
in patients admitted with a ST-elevation myocardial infarc-
tion (STEMI). All included patients (n = 103) had successful 
revascularization and 3-vessel virtual histology intravascular 
ultrasound (VH-IVUS) and optical coherence tomography 
(OCT) imaging at baseline and 13-month follow-up.
The PROSPECT study was a prospective large-scale 
invasive imaging study that aimed to examine the ability 
of VH-IVUS in detecting vulnerable plaques that would 
evolve and cause events. The study included 697 patients 
admitted with an acute coronary syndrome that had 3-ves-
sel VH-IVUS imaging of the proximal 60–80 mm segment 
and successful percutaneous coronary intervention (PCI) 
in all the flow limiting lesions.
The patients recruited in the IBIS-4 study were fol-
lowed-up for a median of 5 years whereas those in the 
PROSPECT trial for 3.4 years. The clinical, angiographic 
and intravascular imaging data in both studies allowed 
detection of untreated lesions that were assessed by 
VH-IVUS at baseline and caused cardiovascular events 
(defined as cardiac death, myocardial infarction, or revas-
cularization because of progressive or unstable angina). 
In addition, in the IBIS-4 study lesions that exhibited 
disease progression and a significant stenosis (% diam-
eter stenosis, DS ≥ 70% on QCA) or an intermediate 
stenosis (70% ≥ %DS ≥ 50%) associated with recurrent 
angina or evidence of ischemia during exercise test at 
13 months with follow-up angiography were considered 
culprit and underwent revascularization. The primary end-
points of the study were lesions assessed by VH-IVUS at 
baseline that either progressed and required revasculariza-
tion on repeat angiography, or lesions that caused cardiac 
death, myocardial infarction, or revascularization because 
of progressive or unstable angina (MACE).
In the IBIS-4 study all the lesions associated with 
MACE had either a thin (TCFA, n = 13) or a thick-cap 
fibroatheroma (ThCFA, n = 2) phenotype. In the PROS-
PECT study 43 of the lesions that were studied by VH-
IVUS at baseline and caused events had a fibroatheroma 
phenotype (TCFA, n = 25; ThCFA, n = 18), 7 had a non-
fibroatheroma phenotype and 4 were unclassified lesions 
[9, 10]. From these 43 lesions, we analysed only data from 
the lesions that were included in the PROSPECT endothe-
lial shear stress (ESS) sub-study, a study that aimed to 
investigate the prognostic value of ESS in predicting 
events [11]. The PROSPECT ESS sub-study included 
lesions where matching of VH-IVUS and X-ray angiog-
raphy was feasible and lesions that had a length ≥ 9 mm 
and a vulnerable phenotype (TCFA, ThCFA). In addition, 
we included a control group of lesions with a vulnerable 
phenotype that remained quiescent from: (1) the PROS-
PECT ESS sub-study and from (2) the patients recruited 
in the IBIS-4 study in Bern University Hospital. Lesions 
with suboptimal angiographic images (for instance vessel 
overlapping or foreshortening or poor opacification of the 
lumen silhouette) and cases where the DICOM file did not 
include all the required information for QFR analysis were 
excluded from the study.
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VH‑IVUS analysis
VH-IVUS analysis was carried out by independent core-lab-
oratories (Cardialysis B.V., Rotterdam, The Netherlands in 
IBIS-4 and Cardiovascular Research Foundation, New York, 
NY in PROSPECT) using dedicated software (QIvus, Medis, 
Leiden, The Netherlands for the IBIS-4 study and QCU-
CMS, Medis, Leiden, the Netherlands for the PROSPECT 
study). In the IBIS-4 study, analysis was performed only for 
the segment that was evaluated by VH-IVUS at baseline and 
follow-up, whereas in the PROSPECT study the analysis was 
carried out for the entire imaged coronary artery.
VH-IVUS segmentation was carried out at every end-
diastolic frame; in each frame the lumen and external elas-
tic membrane (EEM) area were annotated and their dimen-
sions, the plaque area and burden (PB) and its composition 
(fibrotic, fibrofatty, calcific and necrotic core area and bur-
den) were estimated. In the studied segments, lesions were 
characterised as ≥ 3 consecutive VH-IVUS frames with 
PB ≥ 40%; in each lesion the plaque composition was used 
to classify it to one of the following phenotypes: pathologic 
intimal thickening, fibrotic, fibrocalcific, TCFA and ThCFA 
[12].
3D‑QCA reconstruction
Anatomical landmarks such as side branches observed in 
X-ray angiography and VH-IVUS were utilised to deter-
mine the distal and proximal ends of the segment that was 
evaluated by VH-IVUS on coronary angiography. Two end-
diastolic angiographic projections that were more than 25° 
apart, where there was no foreshortening or overlapping of 
the segment of interest and permitted accurate delineation of 
the lumen silhouette were chosen to reconstruct its anatomy. 
This was carried out using an established and well-validated 
software (QAngio XA 3D RE, Medis, Leiden, the Nether-
lands) [13]. In the obtained geometries the lesion length, 
DS and minimum lumen diameter (MLD) were estimated.
QFR analysis
QFR was computed using the Medis Suite XA/QAngio XA 
3D/QFR software (Medis, Leiden, the Netherlands). QFR 
was computed using two approaches: (1) assuming a fixed 
blood flow (fQFR) and (2) taking into account the flow 
velocity estimated by the time needed for the contrast agent 
to fill the segment of interest which is known as contrast-
flow QFR (cQFR) [3].
Statistical methods
Numerical variables are presented as median and interquar-
tile ranges while categorical variables as absolute values 
and percentages. Comparison between numerical variables 
were performed using the Mann–Whitney U test while cat-
egorical variables were compared using the chi-square test. 
Cox regression analysis was used to identify VH-IVUS, 
3D-QCA-derived and QFR predictors associated with 
MACE. For the 3D-QCA and QFR variables associated with 
MACE (P < 0.05) receiver-operating characteristics (ROC) 
curve analysis was performed to identify the best cut-off 
that predicted MACE. The variables with the highest area 
under the curve (AUC) that were not co-linear (r > 0.5) were 
entered into a multivariable model to identify independent 
predictors of MACE.
VH-IVUS and QFR variables were used to classify the 
lesions into groups. Kaplan–Meier plots were used to display 
time to event; comparison of MACE rate between groups 
with different plaque characteristics and QFR values was 
performed using the log-rank test. Analyses were performed 
in Stata (version 15.1, StataCorp LP, College Station, TX) 
and SPSS (version 23; IBM Corp, Armonk, NY, USA). A 
P-value < 0.05 was considered statistically significant.
Results
Patient demographics
QFR analysis was possible in 17 MACE lesions with a thin 
or thick cap fibroatheroma phenotype (5 from the PROS-
PECT ESS study and 12 from the IBIS-4 study) (Fig. 1). 
From the 122 lesions that were included in the PROSPECT 
ESS study and did not cause events, 8 were excluded from 
the present analysis because of suboptimal angiographic 
views and 102 were excluded because of insufficient infor-
mation in the DICOM file for QFR analysis. From the 78 
thin or thick cap fibroatheromas that were recruited in the 
IBIS-4 study from Bern University Hospital, 12 lesions were 
excluded from the present analysis because of suboptimal 
angiographic views. Therefore the final analysis included 
17 MACE lesions and a control group of 78 lesions that 
remained quiescent.
The baseline characteristics of the patients (n = 60) 
included in the present analysis are shown in Table 1. There 
were no differences in the baseline demographics between 
patients who had a MACE and those that did not have an 
event.
Lesions characteristics
Table 2 shows the morphological and angiographic vari-
ables as well as the QFR values in the studied lesions. All 
the studied lesions were non-flow limiting by QFR (range: 
0.81–1.00).
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MACE lesions had a smaller MLA and greater PB on 
VH-IVUS compared to non-MACE lesions. On 3D-QCA 
analysis MACE lesions were longer than the non-MACE 
lesions and had increased %DS but there were no differences 
in the MLD between groups. Both cQFR and fQFR were 
lower in the lesions that caused MACE.
Predictors of MACE lesions
Two VH-IVUS-derived variables (MLA and PB), two 
3D-QCA-derived variables (lesion length and MLD) and 
the fQFR and cQFR indices were predictors of MACE in 
univariate analysis (Table 3). In ROC curve analysis PB 
(AUC: 0.751, P = 0.001), MLA (AUC: 0.734, P = 0.003) 
and cQFR (cutoff 0.97; AUC: 0.733, P = 0.003) were the 
three variables that had the highest AUC for predict-
ing MACE (AUC for fQFR: 0.716, P = 0.005). In the 
multivariable analysis that included cQFR and the pres-
ence of lesions with PB > 70% and small MLA < 4.0 mm2, 
a small cQFR (< 0.97) was independently associated with 
future events (HR 3.53, 95% CI 1.16–10.75; P = 0.027); in 
this model the presence of lesions with increased PB and 
small MLA was not an independent predictor of MACE 
(HR 1.87, 95% CI 0.64–5.43; P = 0.252; Fig. 2). 
Lesions were classified into 4 groups according to the 
presence of ≥ 2 out of the 3 high-risk plaque character-
istics that in the PROSPECT study were associated with 
MACE (MLA ≤ 4 mm2, PB ≥ 70%, TCFA phenotype) and 
the cQFR value (< 0.97). Lesions with high-risk plaque 
characteristics and low cQFR had worse prognosis than 
the other lesions. Similar results were obtained when a 
high-risk plaque phenotype was defined as the presence 
of MLA ≤ 4 mm2 and PB ≥ 70% (Fig. 3a, b).
Fig. 1  Flowchart of study design
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Discussion
In this study, we have for the first time examined the value 
of the computationally derived FFR estimated from the 
QFR software in identifying non-flow limiting lesions with 
a vulnerable-lipid-rich phenotype that are likely to progress 
and cause MACE within 5-year follow-up. We analysed 
data from two large-scale intravascular imaging studies and 
found that the QFR software provides additional prognostic 
information and that together with the plaque characteristics 
derived by VH-IVUS enables more accurate detection of the 
lesions associated with MACE-R.
Large scale prospective intravascular imaging studies of 
coronary atherosclerosis have demonstrated that an inva-
sive assessment of plaque morphology allows detection of 
high-risk plaque features and identification of lesions that 
are likely to progress and cause events [9, 14–16]. However, 
in these studies the positive predictive value of the studied 
invasive imaging modalities in predicting MACE was low. 
Therefore their routine use to stratify risk in the clinical set-
ting is currently not recommended [17]. Combination of 
plaque morphology and physiology, particularly estima-
tion of the ESS using computational fluid dynamic analysis 
of intravascular imaging data seems to provide additional 
prognostic information and detection of vulnerable plaques 
with a positive predictive value that exceeds > 50% [11, 18]. 
However, ESS computation is a time consuming process that 
requires dedicated software and expertise, facts that limit its 
broad use in clinical practice.
FFR was introduced to assess in real time the physio-
logic implications of coronary lesions and detect those that 
cause flow obstruction and ischemia. Reports have shown an 
inverse association between baseline FFR and the incidence 
of future events, highlighting the prognostic value of this 
metric, even in non-flow limiting lesions [19, 20]. Studies 
also support a high agreement between FFR and QFR in 
patients with an acute coronary syndrome and underscore 
the value of QFR in detecting lesions that are likely to pro-
gress and cause events [21, 22]. The prognostic value of 
QFR/FFR is also supported by reports comparing their esti-
mations with IVUS imaging variables, these studies show a 
weak but statistically significant correlation between MLA 
or PB and the FFR values. Moreover, the COMPETE-OCT 
sub-study and a recent report that used multimodality intra-
vascular imaging to assess plaque morphology demonstrated 
that significant stenoses are more likely to have a vulnerable 
phenotype [23, 24]. These findings indicate that there is an 
association between low FFR values and high-risk plaque 
Table 1  Studied patients’ 
baseline demographics
BMI body mass index, CAD coronary artery disease, MACE major adverse cardiovascular event, NSTEMI 
non-ST-elevation myocardial infarction, PCI percutaneous coronary intervention, RAAS renin angiotensin 
aldosterone system, STEMI ST-elevation myocardial infarction
* Renal failure was defined as estimated glomerular filtration rate < 60 mL/min/1.73 m2
Studied patients 
(N = 60)
Non-MACE group 
(N = 44)
MACE group (N = 16) P
Age (years) 57.1 ± 10.13 56.8 ± 10.4 57.7 ± 9.6 0.707
Gender (male) 55 (92%) 40 (91%) 15 (94%) 1.000
BMI 27.7 ± 4.2 27.6 ± 4.4 27.9 ± 3.8 0.498
Current smoker 29 (48%) 18 (41%) 11 (68.8%) 0.056
Co-morbidities
 Diabetes mellitus 8 (13%) 5 (11%) 3 (19%) 0.429
 Hypertension 27 (45%) 21 (48%) 6 (38%) 0.481
 Hypercholesterolemia 25 (43%) 20 (46%) 5 (36%) 0.522
 Renal failure* 2 (4%) 1 (2%) 1 (8%) 0.414
 Previous PCI 4 (7%) 3 (7%) 1 (6%) 1.000
 Family history of CAD 20 (34%) 15 (34%) 5 (33%) 0.957
Clinical presentation 0.739
 STEMI 51 (85%) 38 (86%) 13 (81%)
 NSTEMI 7 (12%) 5 (11%) 2 (13%)
 Unstable angina 2 (3%) 1 (2%) 1 (6%)
Medications at discharge
 Aspirin 60 (100%) 44 (100%) 16 (100%) -
 Thienopyridines 60 (100%) 44 (100%) 16 (100%) -
 Beta-blocker 56 (93%) 42 (96%) 14 (88%) 0.287
 RAAS inhibitor 55 (92%) 42 (96%) 13 (81%) 0.112
 Statin 60 (100%) 44 (100%) 16 (100%) –
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features (i.e., MLA, PB and a vulnerable phenotype) that 
are predictors of future events.
The present study examined for the first time the com-
bined value of computationally-derived FFR and plaque 
morphology in predicting events. We analysed data from 
the PROSPECT and IBIS-4 studies and used an estab-
lished software that is capable of retrospectively process-
ing angiographic imaging data to derive FFR [7]. We found 
that QFR provided additional prognostic information to 
plaque morphology and enabled more accurate prediction 
of MACE. In particular 40.4% of the lesions with high risk 
plaque characteristics and low QFR values caused MACE 
while the event rate was lower in lesions with QFR ≥ 0.96 
or a non-high risk plaque morphology. These findings high-
light the potential importance of the combined assessment 
of plaque morphology and physiology for more accurate 
characterisation of plaque vulnerability. Future prospective 
studies or retrospective analyses of currently ongoing intra-
vascular imaging studies of atherosclerosis should be per-
formed to validate the findings from the present report. Such 
studies may provide insight about the predictive efficacy of 
this approach in detecting vulnerable plaques and high-risk 
patients who might benefit from an aggressive treatment of 
atherosclerosis [25, 26].
Advances in image processing and computational meth-
ods are anticipated to facilitate research towards this direc-
tion. Several solutions have been proposed in the literature 
for intravascular imaging analysis and fast computation 
of the pressure gradient across a lesion at rest or during 
hyperemia [27–29]. The OFR software is the first user-
friendly tool that enables real-time segmentation of OCT 
data and evaluation of lesion severity using computational 
modelling. Validation of this approach has shown a high 
Table 2  Intravascular imaging, 
angiographic and hemodynamic 
characteristics of the studied 
lesions
MACE-R lesions
(N = 17)
Non-MACE-R lesions (N = 78) P
IVUS-VH plaque characteristics
 Lesion length (mm) 23.8 (12.6, 34.6) 26.4 (19.2, 38.0) 0.313
 MLA  (mm2) 3.59 (3.16, 4.51) 5.04 (3.77, 6.52) 0.003
 EEM area  (mm2) 11.62 (10.87, 14.66) 13.67 (10.79, 16.15) 0.557
 Plaque area  (mm2) 8.69 (7.10, 10.51) 7.83 (6.57, 10.72) 0.449
 PB (%) 70.4 (63.5, 72.2) 61.0 (53.3, 67.6) 0.001
 TCFA phenotype 12 (71%) 61 (78%) 0.500
QCA derived variables
 Lesion length 16.6 (10.7, 20.6) 9.3 (6.2, 14.5) 0.008
 MLD 1.90 (1.60, 2.10) 2.00 (1.70, 2.40) 0.192
 Diameter stenosis 35.0 (30.6, 41.1) 28.7 (23.7, 39.0) 0.029
QFR derived variables
 Fixed QFR 0.95 (0.93, 0.98) 0.99 (0.96, 1.00) 0.005
 Contrast FFR 0.94 (0.90, 0.98) 0.99 (0.95, 1.00) 0.002
Lesion location
 Coronary artery 0.278
  Left anterior descending artery 9 (53%) 33 (42%)
  Left circumflex artery 7 (41%) 23 (30%)
  Right coronary artery 1 (6%) 21 (27%)
  Intermediate coronary artery 0 (0%) 1 (1%)
 Coronary segment 0.965
  Proximal vessel 13 (76%) 59 (76%)
  Mid vessel 3 (18%) 13 (17%)
  Distal vessel 1 (6%) 6 (8%)
Table 3  Univariable analyses of the IVUS, QCA-derived predictors 
of MACE-R lesions
Univariable analysis
Hazard ratio P
IVUS-derived variables
 MLA (per  1mm2 increase) 0.51 (0.32, 0.79) 0.003
 PB (per 1% increase) 1.11 (1.05, 1.18) 0.001
QCA-derived variables
 Lesion length (per 1 mm increase) 1.10 (1.01, 1.09) 0.010
 MLD (per 1 mm increase) 0.34 (0.12, 0.92) 0.033
 fQFR (per 0.1 unit increase) 0.36 (0.16, 0.81) 0.013
 cQFR (per 0.1 increase) 0.43 (0.21, 0.89) 0.022
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agreement between OFR and FFR estimations [30, 31]. 
Similar software are expected to be designed in the future 
for the analysis of IVUS imaging data and used to predict 
more accurately lesions that are likely to progress and cause 
events compared to standalone imaging.
Study limitations
The key limitations of the present retrospective study is the 
fact that a large proportion of lesions were excluded from the 
analysis. This is because either accurate co-registration of 
Fig. 2  Case examples that underscore the additional value of QFR 
in predicting lesions associated with MACE-R. a Shows the angio-
graphic projection of a lesion that progressed and required revascu-
larization at 1-year follow-up. VH-IVUS assessment of this lesion 
demonstrated a ThCFA phenotype with a MLA of 4.11  mm2 and a 
PB of 71.7% (b). c Shows the QCA analysis of the segment assessed 
by VH-IVHS which indicates a minor stenosis (MLD: 2.0 mm, DS: 
42.0%), while (d) the estimated QFR values (fQFR: 0.94, cQFR: 
0.94). e Portrays the angiographic projection of a lesion that remained 
quiescent. VH-IVUS examination demonstrated a TCFA phenotype 
with a MLA of 3.77 mm2 and PB of 60.9% (f) while in the QCA anal-
ysis, the estimated MLD and %DS were similar to the previous lesion 
(MLD: 2.0 mm, %DS: 34.5) (g). In this occasion however, the QFR 
values were higher (fQFR: 0.98, cQFR: 0.97) than the lesion that pro-
gressed and required revascularisation (h).
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IVUS and X-ray imaging was not possible or/and the DICOM 
information required to estimate QFR was not available in 
the angiograms acquired in the PROSPECT study. In addi-
tion, QFR analysis was performed in angiographic data that 
had already been acquired; a fact that may have affected the 
accuracy of QFR in assessing the hemodynamic severity of 
a lesion. Moreover, the number of events reported was small 
and thus in order to avoid model overfitting we included in the 
multivariate model only 2 non-colinear variables—presence of 
PB > 70% and MLA < 4 mm2 and QFR—out of the 6 variables 
that were associated with MACE in the univariate analysis. 
Therefore, this analysis should be considered as an exploratory 
and hypothesis generating analysis requiring validation from 
larger studies. Moreover, VH-IVUS imaging was carried out 
using two different imaging systems (s5 in IBIS-4 and Invision 
Gold in PROSPECT); VH assessment from these two systems 
could give different estimations for plaque composition but 
we believe that it will have less effect in the estimation of 
plaque phenotype. In addition, the analysis of the VH-IVUS 
data was performed by two different core-labs, however they 
are in close collaboration and use the same classification algo-
rithm to define plaque phenotype [12]. Finally, the follow-up 
period (median 3.4 years in PROSPECT and 5 years in IBIS-4) 
and the clinical end-points were different in the two studies 
as the IBIS-4 study also reported revascularizations because of 
disease progression in coronary angiography and established 
evidence of ischemia at 13 months follow-up.
Conclusions
In the present post-hoc analysis, assessment of plaque physi-
ology using commercially available QFR software appears to 
provide additional prognostic information and more accurate 
identification of lesions that are likely to progress and cause 
MACE at 5-year follow-up compared to VH-IVUS derived 
plaque morphology alone. However, the small number of 
events reported do not allow us to draw firm conclusions. 
Therefore, further confirmatory research is needed in a 
larger number of patients to quantify the predictive accu-
racy of combined QFR and intravascular imaging for the 
identification of vulnerable plaques and vulnerable patients.
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